Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine D2 Receptor Blocking Peptide (AC1351)
Cat.#: ACPP-1351
Specifications
Despition Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1774 Human CRKL Protein (AC1774) 5 µg inquiry ACPP-1034 Recombinant Human NG2 Protein (6×His Tag) (AC1034) 50 µg inquiry ACPP-1545 Human YWHAG Protein (AC1545) 5 µg inquiry ACPP-1314 Syndecan-1 Blocking Peptide (AC1314) 250 µg inquiry ACPP-1047 Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) 50 µg inquiry ACPP-1796 Human GAP43 Protein (AC1796) 2 µg inquiry ACPP-1334 DRP1 Blocking Peptide (AC1334) 250 µg inquiry ACPP-1724 Human FGF13 Protein (AC1724) 5 µg inquiry ACPP-1494 beta Catenin Blocking Peptide (AC1494) 250 µg inquiry ACPP-1840 Human ALDH1A1 Protein (AC1840) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket